No Data
Kaineng Health: 2024 Annual Report Summary
Kaineng Health: 2024 Annual Report
Kaineng Health: Report for the first quarter of 2025
Canature Health Technology (300272.SZ): Net income for the first quarter is 24.8109 million yuan, a year-on-year increase of 11.30%.
Gelonghui, April 28 - Canature Health Technology (300272.SZ) announced its Q1 2025 report, with a revenue of 0.405 billion yuan, a year-on-year increase of 6.31%; Net income attributable to shareholders of the listed company was 24.8109 million yuan, a year-on-year increase of 11.30%; Net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 23.9992 million yuan, a year-on-year increase of 17.06%; Basic EPS was 0.0439 yuan.
Canature Health Technology Co., Ltd.'s (SZSE:300272) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Canature Health Technology (300272.SZ): There is no direct business cooperation with Mixue Group.
On March 6, Gelonghui reported that Canature Health Technology (300272.SZ) stated on the investor interaction platform that, in the Dining channel, the company has established direct business cooperation with Costa Coffee, Tims Coffee, etc., and has no direct business cooperation with Mixue Group, and it is unclear whether Dealers have any business dealings with them.
Canature Health Technology Co., Ltd. (SZSE:300272) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
